42 results
8-K
EX-4.1
IKT
Inhibikase Therapeutics Inc
20 May 24
Inhibikase Therapeutics Announces Pricing of Registered Direct Offering and Warrant
8:55am
8-K
EX-4.5
IKT
Inhibikase Therapeutics Inc
20 May 24
Inhibikase Therapeutics Announces Pricing of Registered Direct Offering and Warrant
8:55am
8-K
EX-4.2
IKT
Inhibikase Therapeutics Inc
20 May 24
Inhibikase Therapeutics Announces Pricing of Registered Direct Offering and Warrant
8:55am
8-K
EX-4.3
IKT
Inhibikase Therapeutics Inc
20 May 24
Inhibikase Therapeutics Announces Pricing of Registered Direct Offering and Warrant
8:55am
8-K
EX-4.4
IKT
Inhibikase Therapeutics Inc
20 May 24
Inhibikase Therapeutics Announces Pricing of Registered Direct Offering and Warrant
8:55am
8-K
EX-4.6
xkfq8
20 May 24
Inhibikase Therapeutics Announces Pricing of Registered Direct Offering and Warrant
8:55am
8-K
EX-4.2
oxe9j
26 Jan 23
Inhibikase Therapeutics Announces $10 Million Concurrent Registered Direct Offering
4:02pm
8-K
EX-4.1
0pthrquscltv9f8gv
26 Jan 23
Inhibikase Therapeutics Announces $10 Million Concurrent Registered Direct Offering
4:02pm
8-K
EX-4.3
afybun5 9l93wl5gl8
26 Jan 23
Inhibikase Therapeutics Announces $10 Million Concurrent Registered Direct Offering
4:02pm
8-K
EX-4.4
7lyl5b3ok1cf
26 Jan 23
Inhibikase Therapeutics Announces $10 Million Concurrent Registered Direct Offering
4:02pm
8-K
EX-4.5
hjifwjffm327
26 Jan 23
Inhibikase Therapeutics Announces $10 Million Concurrent Registered Direct Offering
4:02pm
S-3
EX-4.2
ziqja brfxw
7 Feb 22
Shelf registration
12:00am
8-K
EX-4.1
vgl 9o4nrcsva
16 Jun 21
Inhibikase Therapeutics Prices Follow-On Public Offering of Common Stock
9:20am
DRS
EX-4.19
fs1yyqkiiadx
2 Jun 21
Draft registration statement
12:00am